Showing results (21-30 of 65) with videos related to
Sort By:
Pageof 7
Pharmacological Research|February 29, 2020
The role of small molecule Flt3 receptor protein-tyrosine kinase inhibitors in the treatment of Flt3-positive acute myelogenous leukemiasRobert RoskoskiPharmacological Research|January 12, 2024
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 updateRobert RoskoskiPharmacological Research|February 7, 2018
The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disordersRobert RoskoskiPharmacological Research|July 25, 2015
A historical overview of protein kinases and their targeted small molecule inhibitorsRobert RoskoskiPharmacological Research|May 10, 2021
Hydrophobic and polar interactions of FDA-approved small molecule protein kinase inhibitors with their target enzymesRobert RoskoskiPharmacological Research|December 5, 2025
Poly (ADP-ribose) polymerase (PARP) inhibitors approved for the treatment of cancerRobert RoskoskiPharmacological Research|March 21, 2016
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugsRobert RoskoskiPharmacological Research|July 25, 2022
Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disordersRobert RoskoskiPharmacological Research|July 16, 2023
Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United StatesRobert RoskoskiPharmacological Research|December 4, 2018
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugsRobert RoskoskiPageof 7